| Primary |
| Drug Use For Unknown Indication |
25.0% |
| Dyspepsia |
12.5% |
| Epigastric Discomfort |
12.5% |
| Hyperphosphataemia |
12.5% |
| Osteoarthritis |
12.5% |
| Periarthritis |
12.5% |
| Prophylaxis |
12.5% |
|
| Drug Ineffective |
16.7% |
| Movement Disorder |
16.7% |
| Polyuria |
16.7% |
| Self-medication |
16.7% |
| Stomach Discomfort |
16.7% |
| Vomiting |
16.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
40.7% |
| Cardiac Failure |
7.4% |
| Dyspepsia |
7.4% |
| Gastric Ulcer |
7.4% |
| Hyperphosphataemia |
7.4% |
| Osteoarthritis |
7.4% |
| Osteoporosis |
7.4% |
| Bronchitis Chronic |
3.7% |
| Depression |
3.7% |
| Hypertension |
3.7% |
| Pain |
3.7% |
|
| Red Blood Cell Count Decreased |
22.2% |
| Hypercalcaemia |
11.1% |
| Multiple Drug Overdose Intentional |
11.1% |
| Nephrolithiasis |
11.1% |
| Polyuria |
11.1% |
| Renal Failure Acute |
11.1% |
| Tachycardia |
11.1% |
| Tremor |
11.1% |
|
| Concomitant |
| Multiple Myeloma |
21.8% |
| Osteoporosis |
19.7% |
| Prophylaxis Against Transplant Rejection |
6.1% |
| Nuclear Magnetic Resonance Imaging |
5.2% |
| Chronic Lymphocytic Leukaemia |
4.5% |
| Plasma Cell Myeloma |
4.5% |
| Drug Use For Unknown Indication |
4.2% |
| Hyperphosphataemia |
3.9% |
| Pulmonary Hypertension |
3.9% |
| Fabry's Disease |
3.6% |
| Pain |
3.3% |
| Hypertension |
3.0% |
| Myelodysplastic Syndrome |
2.7% |
| Osteoporosis Prophylaxis |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Acute Lymphocytic Leukaemia |
1.8% |
| Convulsion |
1.8% |
| Depression |
1.8% |
| Ill-defined Disorder |
1.8% |
| Mantle Cell Lymphoma |
1.8% |
|
| Vomiting |
14.8% |
| Renal Failure Acute |
7.8% |
| Urinary Tract Infection |
7.8% |
| White Blood Cell Count Decreased |
7.0% |
| Urticaria |
6.3% |
| Weight Decreased |
6.3% |
| Tachycardia |
5.5% |
| Thrombocytopenia |
4.7% |
| International Normalised Ratio Increased |
3.9% |
| Pain |
3.9% |
| Thyroid Disorder |
3.9% |
| Gastrointestinal Haemorrhage |
3.1% |
| Hyponatraemia |
3.1% |
| Oesophagitis |
3.1% |
| Pharmaceutical Product Complaint |
3.1% |
| Pneumonia |
3.1% |
| Respiratory Arrest |
3.1% |
| Sepsis |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Xerosis |
3.1% |
|
